Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,998 GBX | +1.68% |
|
+1.47% | +11.91% |
Jun. 17 | Transcript : Hikma Pharmaceuticals PLC, Xellia Pharmaceuticals ApS, Xellia Pharmaceuticals - M&A Call | |
Jun. 17 | Hikma adds scale to US injectables business with Xellia acquisition | AN |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.91% | 5.53B | |
+52.38% | 797B | |
+40.30% | 628B | |
-7.25% | 351B | |
+16.63% | 323B | |
+10.96% | 300B | |
+17.04% | 244B | |
+1.23% | 223B | |
+5.32% | 163B | |
-5.30% | 153B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Transcript : Hikma Pharmaceuticals PLC Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 09